| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 12, 2022 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 400 | $333.50 | $133,400.40 | - | +9.0% | +88.6% | |
| Oct 10, 2022 | LLY Eli Lilly & Co | Weems Alonzo | EVP, Erm &Ceco | Sell | 656 | $326.23 | $214,006.88 | -8.6% | +8.3% | +79.4% | |
| Oct 7, 2022 | PCRX Pacira Biosciences, Inc. | Reinhardt Max79 | President, Rest Of World | Sell | 1,380 | $58.00 | $80,040.00 | -4.2% | -31.6% | -47.1% | |
| Oct 6, 2022 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 149,264 | $334.54 | $49,934,081.74 | - | +9.4% | +70.2% | |
| Oct 6, 2022 | UTHR United Therapeutics Corp | Mahon Paul A47 | EVP &General Counsel | Sell | 6,000 | $209.26 | $1,255,560.84 | -7.3% | +30.0% | +11.7% | |
| Oct 5, 2022 | TLRY Tilray Brands, Inc. | Kennedy Brendan87 | Director | Sell | 350,000 | $2.91 | $1,018,395.00 | -5.1% | -7.7% | -28.9% | |
| Oct 4, 2022 | NBIX Neurocrine Biosciences Inc | Lyons Gary A54 | Director | Sell | 5,000 | $110.54 | $552,711.00 | -2.4% | +9.9% | +1.3% | |
| Oct 4, 2022 | NBIX Neurocrine Biosciences Inc | Lippoldt Darin60 | Chief Legal Officer | Sell | 10,000 | $111.04 | $1,110,446.00 | -25.5% | +9.9% | +1.3% | |
| Oct 4, 2022 | COLL Collegium Pharmaceutical, Inc | Tupper Colleen45 | EVP &Chief Financial Officer | Sell | 4,350 | $17.35 | $75,472.50 | -4.6% | +35.1% | +35.1% | |
| Oct 4, 2022 | DERM Journey Medical Corp | De Paolantonio Ernest Robert | Chief Financial Officer | Sell | 10,093 | $2.41 | $24,324.13 | -3.7% | -23.0% | +17.8% | |
| Oct 3, 2022 | IRWD Ironwood Pharmaceuticals Inc | McCourt Thomas A66 | Chief Executive Officer | Sell | 18,899 | $10.41 | $196,738.59 | -2.6% | +18.3% | -6.5% | |
| Oct 3, 2022 | NBIX Neurocrine Biosciences Inc | Boyer David W.51 | Chief Corp. Affairs Officer | Sell | 1,437 | $106.59 | $153,169.83 | -25.4% | +12.5% | +3.6% | |
| Oct 3, 2022 | UTHR United Therapeutics Corp | Sullivan Louis W62 | Director | Sell | 710 | $211.56 | $150,207.60 | -5.5% | +27.8% | +3.5% | |
| Oct 3, 2022 | AMPH Amphastar Pharmaceuticals, Inc. | Petersen Floyd F.51 | Director | Sell | 500 | $28.59 | $14,296.15 | -0.6% | -0.7% | +58.0% | |
| Sep 30, 2022 | TXMD Therapeuticsmd, Inc. | Rubric Capital Management LP | 10% Owner | Buy | 7,000 | $1,000.00 | $7,000,000.00 | +46.7% | -15.2% | -54.5% | |
| Sep 30, 2022 | HROW Harrow, Inc. | Lindstrom Richard L Md65 | Director | Sell | 40,000 | $12.62 | $504,800.00 | -60.5% | +22.5% | +19.1% | |
| Sep 30, 2022 | PLNH Planet 13 Holdings Inc. | Jennings Michael Lanteri | Pres. Of East Coast Operations | Sell | 17,500 | $1.08 | $18,851.00 | -0.7% | - | - | |
| Sep 29, 2022 | UTHR United Therapeutics Corp | Mesa Nilda47 | Director | Sell | 1,250 | $209.87 | $262,334.51 | -8.6% | +31.5% | +8.6% | |
| Sep 29, 2022 | PLNH Planet 13 Holdings Inc. | Jennings Michael Lanteri | Pres. Of East Coast Operations | Sell | 52,500 | $1.09 | $57,137.50 | -1.1% | - | - | |
| Sep 28, 2022 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 101,631 | $335.07 | $34,053,649.84 | - | +9.4% | +63.3% | |
| Sep 28, 2022 | TSNDF Terrascend Corp. | Jw Asset Management, LLC65 | Executive Chairman | Buy | 65,000 | $1.36 | $88,192.00 | - | - | - | |
| Sep 28, 2022 | HROW Harrow, Inc. | Opaleye Management Inc.60 | 10% Owner | Buy | 11,085 | $9.77 | $108,353.66 | +0.3% | +40.2% | +44.8% | |
| Sep 27, 2022 | VRNO Verano Holdings Corp. | Archos George Peter | Chief Executive Officer | Sell | 54,570 | $4.76 | $259,616.78 | -4.3% | - | - | |
| Sep 27, 2022 | TSNDF Terrascend Corp. | Jw Asset Management, LLC65 | Executive Chairman | Buy | 10,000 | $1.32 | $13,198.00 | - | - | - | |
| Sep 27, 2022 | PLNH Planet 13 Holdings Inc. | Jennings Michael Lanteri | Pres. Of East Coast Operations | Sell | 70,000 | $1.14 | $79,471.00 | -1.4% | - | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.